OMICS International

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer

 

Recommended Conferences for Bioavailability bioequivalence studies

Bioavailability bioequivalence studies


As per available reports about 43 relevant Journals, 38 Conferences, 3 Workshops are presently dedicated exclusively to Bioavailability and Bioequivalence Studies and about 335 articles are being published on bioavailability bioequivalence studies.

Bioavailability Biequivalence studies  aims to become a regional center of excellence for assuring the safety and efficacy of generic pharmaceutical products for human use. Bioavailability refers to the extent to which a drug is absorbed into the body and is thus available to act upon the drug's intended target, also known as the "site of action. Bioavailability and Bioequivalence Studies Submitted in New Drug Applications or Investigational New Drug Applications-also known as the NDA BA and BE.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.  

Scope and Importance:

Bioequivalence Conference provides the scope for opportunities to learn progressed by international scientists and academicians. So many symposiums have been conducted and are to be organized all across the globe focusing on the significance of Bioequivalence Innovations, Therapeutic Possibilities and Technological Challenges is going to be organized which will focus on Bioequivalence.

The Bioavailability Bioequivalence Studies aims to become a regional center of excellence for assuring the safety and efficacy of generic pharmaceutical products for human use. Bioavailability refers to the extent to which a drug is absorbed into the body and is thus available to act upon the drug's intended target, also known as the "site of action. Bioavailability and Bioequivalence Studies Submitted in New Drug Applications or Investigational New Drug Applications-also known as the NDA BA and BE.

Play a key role in the drug development period for both new drug products and their generic equivalents.  These studies are also important in the post approval period in the presence of certain manufacturing changes. Information in the overall set of data that ensure the availability of safe and effective medicines to patients and practitioners.   BA /BE studies has been determined to have practical and public health value for pharmaceutical sponsors, for regulatory agencies, and for patients and practitioners.
 

Market Analysis:

The global market for generic drugs was worth $81 billion in 2008, $84 billion in 2009, estimated to be $168.7 billion in 2014. Sales of U.S. generic drugs currently dominate the market with $54 billion for the 2014. Japan’s generic drugs market is expected to have the highest rate of growth among major markets at 12.2%, increasing from $5.4 billion in 2009 to $9.6 billion in 2014.By 2016, it is expected that the value of the total global generics sector will have risen to $358 billion. The North American market is estimated to reach to reach nearly $107 billion in 2016 with an increase of 7.9% compound annual growth rate annual growth rate and Emerging market to reach nearly $115 billion.

International symposium and workshops

  • 1st International Gazi Pharma Symposium Series to be held from November 12 to 15, 2015 in Antalya, Turkey.
  • XII International Pharma Licensing Symposium (XII IPLS)
  • International symposium and workshops in November 12, 2014 by New Zealand Drug Foundation
  • IV International Symposium on Drug Discovery in July 22th to 24th, 2015 held at the School of Pharmaceutical Sciences (UNESP), Araraquara, São Paulo, Brazil,
  • International Symposium on Drug Policy and Public Health on 29 September - 1 October 2014 Istanbul, Turkey

List of Best International Conferences:

Associations

  • Bioanalytical Focus Group and Ligand Binding Assay
  • American Association of Pharmaceutical Scientists (AAPS)
  • Royal Netherlands Chemical Society
  • The European Bioanalysis Forum
  • BEBAC Consultancy Services for Bioequivalence and Bioavailability
  • American Thyroid Association
  • Generic Pharmaceutical Association
  • FDA
  • European Generic medicines Association.
  • Therapeutics Goods Administration (TGA)
  • European Economic Area
  • Canadian Generic Pharmaceutical Association (CGPA)
  • Bioequivalence and Bioavailability forum
  • FDA Office of Surveillance and Epidemiology (formerly Drug Safety)
  • Drug Watch
  • ORPHANET Parenteral Drug Association
  • PharmGKB
  • US Food and Drug Administration (FDA)
  • American Association for Clinical Chemistry (AACC)
  • American Association of Pharmaceutical Scientists (AAPS)
  • Clinical Trials Information from National Institutes for Health (NIH)
  • National Institute of Standards and Technology (NIST)

Companies :

  • Myriad RBM, Inc
  • NDI ADRL Inc. dba Diteba
  • BioScience Laboratories, Inc.
  • Pacific BioLabs (PBL)
  • Biological Test Center
  • Algorithme Pharma, Inc.
  • Gateway Analytical
  • Celerion
  • Apotex Inc.
  • PharmaNet Development Group, Inc
  • AstraZeneca
  • Accredo Therapeutics
  • Actelion Pharmaceuticals US, Inc
  • Bayer HealthCare
  • CRITICAL CARE
  • Cané Medical Technology
  • CVS Caremark
  • CuraScript
  • Fairview Specialty Pharmacy
  • Gilead Sciences

This page will be updated regularly.

This page was last updated on 11th Sep, 2015

Conferenceseries Destinations

Contact Us

Medical Conferences
Jessie Grace
jessie.grace@conferenceseries.com
1-702-508-5200 Ext:8031, 8041

Pharmaceutical Conferences
Badoni Victor
badoni.victor@conferenceseries.com
1-702-508-5200 Ext:8045, 8047

Immunology & Microbiology Conferences
Walker Smith
walker.smith@conferenceseries.com
1-702-508-5200 Ext:8031

Cancer Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Nursing and Healthcare Conferences
Jennifer Leny
jennifer.leny@conferenceseries.com
1-702-508-5200 Ext:8044

Diabetes Conferences
Stanley knight
stanley.knight@conferenceseries.com
1-702-508-5200 Ext:8040

Neuroscience Conferences
Sandeep Kumar
sandeep@conferenceseries.com
1-702-508-5200 Ext:8034

Dental Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Clinical and Biochemistry Conferences
Rohit Casper
rohit.casper@conferenceseries.com
1-702-508-5200 Ext:8033

Biotechnology Conferences
Ravi Vittal
ravi.vittal@conferenceseries.com
1-702-508-5200 Ext:8031, 8037

Material Science Conferences
Lucy Grey
lucygrey@conferenceseries.com
1-702-508-5200 Ext:8035

Genetics & Mol Biology Conferences
Stephen Bruce
stephen.bruce@conferenceseries.com
1-702-508-5200 Ext:8038

Engineering Conferences
Dolly A
dolly@conferenceseries.com
+1-702-508-5200 Ext:8051

Program Enquiries
Symposia/Workshops
Sponsorships
Media Partners | Advertising